Page 136 - MEMORIA_SEHH-FEHH_2023
P. 136
MEMORIA ANUAL 2023
SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
GETH
FUNDACIÓN ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
Mussetti A, Bento L, Bastos-Oreiro M, Rius-Sansalvador B, Albo C, Bailén R, Barba P,
Benzaquén A, Briones J, Caballero AC, Campos A, Español I, Ferra C, López SG, Gon-
zález Sierra PA, Guerra LM, Hernani R, Iacoboni G, Jiménez-Ubieto A, Kwon M, Corral
LL, López-Godino O, Munoz MCM, Martínez-Cibrián N, Gómez JM, Pérez-Ortega L, Ortí
G, Ortiz-Maldonado V, Pascual MJ, Perera M, Pérez A, Reguera JL, Sánchez JM, Sanz J,
Torrent A, Yáñez L, Varela R, Echechipia IC, Caballero D, Sureda A.
• Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relaps-
ing after allogeneic hematopoietic cell transplantation: a study of the SFGM-TC.
Bone Marrow Transplant. 2023;58(1):72-9. doi: 10.1038/s41409-022-01846-9.
Chauvet P, Paviglianiti A, Labopin M, Labussière H, Boissel N, Robin M, Maillard N, Oua-
chée-Chardin M, Forcade E, Poiré X, Chantepie S, Huynh A, Bulabois CE, Leclerc M,
Maury S, Chevallier P, Cluzeau T, Mear JB, Cornillon J, Bilger K, Simand C, Beguin Y, Rubio
MT, Yakoub-Agha I, Brissot E.
• One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully
vaccinated hematological patients.
Blood Cancer J. 2023;13(1):8. doi: 10.1038/s41408-022-00778-3.
Piñana JL, Vázquez L, Calabuig M, López-Corral L, Martín-Martín G, Villalón L, Sanz-
Linares G, Conesa-García V, Sánchez-Salinas A, Gago B, Facal A, Risco-Gálvez I, Olave
MT, Espigado I, López-Jiménez J, Hernández-Rivas JÁ, Avendaño-Pita A, Arroyo I, Fe-
rrer E, García-Cadenas I, González-Santillana C, Roldán-Pérez A, Ferrer B, Guerreiro M,
Suarez-Lledó M, Cámara A, Campos-Beltrán D, Navarro D, Cedillo Á, Sureda A, Solano
C; Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-
TC); Martino R.
• Respiratory virus infections after allogeneic stem cell transplantation: Current un-
derstanding, knowledge gaps, and recent advances.
Transpl Infect Dis. 2023;25 Suppl 1:e14117. doi: 10.1111/tid.14117.
Piñana JL, Pérez A, Chorão P, Guerreiro M, García-Cadenas I, Solano C, Martino R, Nava-
rro D; Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell
Transplantation and Cell Therapy Group (GETH-TC).
• Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in
Hematological Patients and Cell Therapy Recipients.
Viruses. 2023;15(10):2066. doi: 10.3390/v15102066.
Piñana JL, Heras I, Aiello TF, García-Cadenas I, Vázquez L, López-Jiménez J, Chorão P,
Aroca C, García-Vidal C, Arroyo I, Soler-Espejo E, López-Corral L, Avendaño-Pita A, Arru-
fat A, García-Gutiérrez V, Arellano E, Hernández-Medina L, González-Santillana C, Morell
136
